Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Biology & Therapy

• Publication date

  2002-08-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cbt.1.5.158PMID 12496470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Role(s) for Integrins in Human Melanoma Invasion

  2004cited by this paper
• Platelet-endothelial cell adhesion molecule-1 (CD31) redistributes from the endothelial junction and is not required for the transendothelial migration of melanoma cells

  2004cited by this paper
• Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma

  2004cited by this paper
• Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail*

  2001cited by this paper
• Gene regulation in melanoma progression by the AP-2 transcription factor.

  2001cited by this paper
• N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells.

  2001cited by this paper
• Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo

  2001cited by this paper
• The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

  2001cited by this paper
• Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.

  2001cited by this paper
• Role of cadherins and matrixins in melanoma

  2001cited by this paper
• Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.

  2000cited by this paper
• Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression.

  2000cited by this paper
• Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.

  2000cited by this paper
• E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

  2000cited by this paper
• Cadherins and tissue formation: integrating adhesion and signaling

  1999cited by this paper
• The role of CD146 (Mel‐CAM) in biology and pathology

  1999cited by this paper
• Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice

  1999cited by this paper
• Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.

  1999cited by this paper
• Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model.

  1998cited by this paper
• Integrin affinity modulation.

  1998cited by this paper
• Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis

  1998cited by this paper
• Loss of AP-2 Results in Up-regulation ofMCAM/MUC18 and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells*

  1998cited by this paper
• A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.

  1998cited by this paper
• Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.

  1998cited by this paper
• Adhesion molecules and tumor metastasis.

  1998cited by this paper
• Cell–cell interactions during transendothelial migration of tumor cells

  1998cited by this paper
• Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.

  1997cited by this paper
• The molecular structure of cell adhesion molecules.

  1997cited by this paper
• Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.

  1997cited by this paper
• Analysis of the expression of intercellular adhesion molecule‐1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non‐glycosylated antigen

  1997cited by this paper
• Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.

  1997cited by this paper
• The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma.

  1997cited by this paper
• Role of cadherins in the transendothelial migration of melanoma cells in culture.

  1997cited by this paper
• Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms.

  1996cited by this paper
• Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3

  1996cited by this paper
• Shifts in cadherin profiles between human normal melanocytes and melanomas.

  1996cited by this paper
• Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.

  1996cited by this paper
• Beta3 integrin expression in melanoma predicts subsequent metastasis.

  1996cited by this paper
• Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.

  1996cited by this paper
• E‐cadherin expression in human melanoma

  1996cited by this paper
• Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1

  1996cited by this paper
• Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

  1996cited by this paper
• Regulation of integrin function.

  1996cited by this paper
• Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.

  1995cited by this paper
• Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma.

  1995cited by this paper
• An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.

  1995cited by this paper
• Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.

  1994cited by this paper
• Isolation and functional characterization of the A32 melanoma-associated antigen.

  1994cited by this paper
• Structural motifs for recognition and adhesion in members of the immunoglobulin superfamily.

  1994cited by this paper
• Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.

  1994cited by this paper
• Adhesion receptors in human melanoma progression.

  1994cited by this paper
• E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro.

  1994cited by this paper
• Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours

  1993cited by this paper
• From adhesion to signalling: roles of integrins in the biology of human melanoma.

  1993cited by this paper
• Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.

  1993cited by this paper
• Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact.

  1993cited by this paper
• The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.

  1993cited by this paper
• Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.

  1993cited by this paper
• Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains.

  1993cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.

  1992cited by this paper
• Role of the alpha v beta 3 integrin in human melanoma cell invasion.

  1992cited by this paper
• Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor.

  1991cited by this paper
• Integrin expression in human melanoma cell lines: Heterogeneity of vitronectin receptor composition and function

  1991cited by this paper
• Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.

  1990cited by this paper
• MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.

  1989cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.

  1989cited by this paper
• Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes

  1987cited by this paper
• Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.

  1987cited by this paper

• The multifaceted roles of MCAM in development, homeostasis, pathological conditions, and cancer

  2025cites this paper
• Differentiation of feline cutaneous round cell tumours using immunohistochemistry.

  2025cites this paper
• Hypocrellin: A Natural Photosensitizer and Nano‐Formulation for Enhanced Molecular Targeting of PDT of Melanoma

  2024cites this paper
• Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials

  2024cites this paper
• Melanoma Cells Produce Large Vesicular-Bodies That Cause Rapid Disruption of Brain Endothelial Barrier-Integrity and Disassembly of Junctional Proteins

  2023cites this paper
• Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma

  2023cites this paper
• Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis

  2022cites this paper
• Single-Cell Technologies: Advances in Single-Cell Migration and Multi-Omics

  2022cites this paper
• Feline Uveal Melanoma Review: Our Current Understanding and Recent Research Advances

  2022cites this paper
• Equivalence framework for an age-structured multistage representation of the cell cycle.

  2021cites this paper
• Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities

  2021cites this paper
• Rethinking the biology of metastatic melanoma: a holistic approach

  2021cites this paper
• Integrative molecular and clinical profiling of acral melanoma identifies LZTR1 as a key tumor promoter and therapeutic target

  2021cites this paper
• Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead

  2021influential citation
• Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up‐regulation and increased apoptosis resistance upon vemurafenib treatment

  2021cites this paper
• A Simplistic Single-Step Method for Preparing Biomimetic Nanoparticles from Endogenous Biomaterials.

  2021cites this paper
• CD146, from a melanoma cell adhesion molecule to a signaling receptor

  2020cites this paper
• Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer

  2020cites this paper
• A Framework of Major Tumor-Promoting Signal Transduction Pathways Implicated in Melanoma-Fibroblast Dialogue

  2020cites this paper
• Cell Adhesion Molecules in Plasticity and Metastasis

  2020cites this paper
• The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.

  2020cites this paper
• S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis

  2020cites this paper
• RGD-HK Peptide-Functionalized Gold Nanorods Emerge as Targeted Biocompatible Nanocarriers for Biomedical Applications

  2019cites this paper
• Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion

  2019cites this paper
• Nonocular Melanocytic Neoplasia in Cats: Characterization and Proposal of a Histologic Classification Scheme to More Accurately Predict Clinical Outcome

  2019cites this paper
• Low‐temperature plasma‐activated medium inhibited invasion and metastasis of melanoma cells via suppressing the Wnt/β‐catenin pathway

  2019cites this paper
• Knockdown MTMR14 promotes cell apoptosis and inhibits migration in liver cancer cells.

  2019cites this paper
• Biology of Melanocytes and Primary Melanoma

  2018cites this paper
• Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype

  2018cites this paper
• Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.

  2018cites this paper
• Computational Simulation Of Networks Dynamics In Cancer Cell Adhesion

  2018cites this paper
• Bupleurum chinense polysaccharide inhibit adhesion of human melanoma cells via blocking β1 integrin function.

  2017cites this paper
• Diet phytochemicals and cutaneous carcinoma chemoprevention: A review

  2017cites this paper
• Rear-polarized Wnt5a-receptor-actin-myosin-polarity (WRAMP) structures promote the speed and persistence of directional cell migration

  2017cites this paper
• Combating malignant melanoma with the multifaceted soy-dervied peptide lunasin.

  2017cites this paper
• 7 Melanoma-Induced Endothelial Cell Growth Involves Phospholipase A 2 and COX 2 Upregulation

  2017cites this paper
• Minimal residual disease in melanoma : circulating melanoma cells and predictive role of MCAM / MUC 18 / MelCAM / CD 146

  2017cites this paper
• Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146

  2017cites this paper
• The Ig VH complementarity-determining region 3-containing Rb9 peptide, inhibits melanoma cells migration and invasion by interactions with Hsp90 and an adhesion G-protein coupled receptor.

  2016cites this paper
• Glycosylation of Integrins in Melanoma Progression

  2016cites this paper
• Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma.

  2016cites this paper
• MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding

  2016cites this paper
• Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET

  2016cites this paper
• Cytological diagnosis of metastatic malignant melanoma by fine-needle aspiration biopsy.

  2016cites this paper
• The Anticancer Activity of Organotelluranes: Potential Role in Integrin Inactivation

  2016cites this paper
• β1,6-branched complex-type N-glycans affect FAK signaling in metastatic melanoma cells

  2016cites this paper
• Compounds for radionuclide imaging and therapy of malignant foci characterized by the increased angiogenesis

  2016cites this paper
• Natural products with therapeutic potential in melanoma metastasis.

  2015cites this paper
• The clinicopathological and gene expression patterns associated with ulceration of primary melanoma

  2015cites this paper
• Role of tumor cell surface lysosome-associated membrane protein-1 (LAMP1) and its associated carbohydrates in lung metastasis

  2015cites this paper
• Expression of estrogen receptors in melanoma and sentinel lymph nodes; a "female" clinical entity or a possible treatment modality?

  2015cites this paper
• Antiangiogenesis, Loss of Cell Adhesion and Apoptosis Are Involved in the Antitumoral Activity of Proteases from V. cundinamarcensis (C. candamarcensis) in Murine Melanoma B16F1

  2015cites this paper
• Extracellular galectin-3 induces MMP9 expression by activating p38 MAPK pathway via lysosome-associated membrane protein-1 (LAMP1)

  2015cites this paper
• PPARγ activation reduces ischemia/reperfusion-induced metastasis in a murine model of hepatocellular carcinoma

  2015cites this paper
• Aberrant glycosylation of αvβ3 integrin is associated with melanoma progression.

  2015cites this paper
• PCR15005 60..64

  2015cites this paper
• Antiangiogenesis, Loss of Cell Adhesion and Apoptosis Are Involved in Antitumoral Activity of Proteases in Murine Melanoma B16F1 V. cundinamarcensis (C. candamarcensis)

  2015cites this paper
• Control of Cell Invasion in Melanoma by a New Gene, FAM129B

  2015cites this paper
• Efeitos das nanocápsulas de núcleo lipídico contendo acetileugenol em melanomas: estudos in vivo e in vitro

  2015cites this paper
• Cytologic Diagnosis of Metastatic Melanoma

  2015cites this paper
• Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma

  2014cites this paper
• Lunasin reduces the melanoma stem cell population in vitro and inhibits tumor proliferation in vivo.

  2014cites this paper
• [18F]Fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ3 and αvβ5 integrins

  2014cites this paper
• Why is melanoma so metastatic?

  2014cites this paper
• Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling.

  2014cites this paper
• Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin

  2014influential citation
• RGDechi-hCit: αvβ3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells

  2014cites this paper
• Low expression of the FoxO4 gene may contribute to the phenomenon of EMT in non-small cell lung cancer.

  2014cites this paper
• Molecular pathology of cutaneous melanoma.

  2014cites this paper
• Molecular testing in Cutaneous Melanoma

  2014cites this paper
• CITOTOXICIDADE E ATIVIDADE ANTITUMORAL DE SAIS DO GALATO DE DODECILA

  2014cites this paper
• Clinical Study Computerized Decision Support System for Intraoperative Analysis of Margin Status in Breast Conservation Therapy

  2014cites this paper
• Multiple types of data are required to identify the mechanisms influencing the spatial expansion of melanoma cell colonies

  2013cites this paper
• Adhesion Molecules in Primary Oral Mucosal Melanoma: Study of Claudins, Integrins and Immunoglobulins in a Series of 35 Cases

  2013cites this paper
• Targeted Therapies in Melanoma: Successes and Pitfalls

  2013cites this paper
• Multivalent presentation of a hydrolytically stable GM(3) lactone mimetic as modulator of melanoma cells motility and adhesion.

  2013cites this paper
• Immune alterations in malignant melanoma and current immunotherapy concepts

  2013influential citation
• Augmenting the Skin Immune System

  2013cites this paper
• Melanoma cells use Thy-1 (CD90) on endothelial cells for metastasis formation.

  2013cites this paper
• In vitro activity of the αvβ3 integrin antagonist RGDechi-hCit on malignant melanoma cells.

  2013cites this paper
• T-Cadherin Stimulates Melanoma Cell Proliferation and Mesenchymal Stromal Cell Recruitment, but Inhibits Angiogenesis in a Mouse Melanoma Model

  2013influential citation
• Impact of E-cadherin expression pattern in melanocytic nevi and cutaneous malignant melanoma.

  2012cites this paper
• Experimental studies on ErbB targeted therapy in malignant melanoma

  2012cites this paper
• Computerized Decision Support System for Intraoperative Analysis of Margin Status in Breast Conservation Therapy

  2012cites this paper
• Effect of COX and LOX inhibitors on melanoma

  2012cites this paper
• Radiolabelled RGD peptides for imaging and therapy

  2012cites this paper
• ¹²⁵I-radiolabeled morpholine-containing arginine-glycine-aspartate (RGD) ligand of αvβ₃ integrin as a molecular imaging probe for angiogenesis.

  2012cites this paper
• c-ABL AND ARG DRIVE CANCER CHEMORESISTANCE VIA ACTIVATION OF MULTIPLE SIGNALING PATHWAYS

  2012cites this paper
• The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis

  2012cites this paper
• Proteomic profiling of human melanoma metastatic cell line secretomes.

  2011cites this paper
• Glycans in melanoma screening. Part 1. The role of β1,6-branched N-linked oligosaccharides in melanoma.

  2011cites this paper
• Transcriptomic Analysis Brings New Insight into the Biological Role of the Prion Protein during Mouse Embryogenesis

  2011cites this paper
• Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnake.

  2011cites this paper
• Neural cell adhesion molecule potentiates invasion and metastasis of melanoma cells through CAMP-dependent protein kinase and phosphatidylinositol 3-kinase pathways.

  2011cites this paper
• Collagen Triple Helix Repeat Containing 1 Promotes Melanoma Cell Adhesion and Survival

  2011cites this paper
• Neural Cell Adhesion Molecule Potentiates the Growth of Murine Melanoma via β-Catenin Signaling by Association with Fibroblast Growth Factor Receptor and Glycogen Synthase Kinase-3β

  2011cites this paper
• Melanoma-Induced Endothelial Cell Growth Involves Phospholipase A2 and COX2 Upregulation

  2011cites this paper
• Dual Function of Wnts in Human Cutaneous Melanoma

  2011cites this paper
• NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway

  2011cites this paper
• Adhesion Therapy: An Endogenous Bioactive Process

  2011cites this paper